Literature DB >> 401372

Myoglobin: methods and diagnostic uses.

L J Kagen1.   

Abstract

Myoglobin is the oxygen-binding protein characteristic of skeletal and cardiac muscle. With muscle disease or dysfunction, myoglobin may enter the circulation, and after renal clearance, it may also appear in the urine. Therefore, the presence of myoglobinemia and myoglobinuria may serve as indicators of the presence and severity of muscle disease. With newly developed methods of detection, myoglobinemia and myoglobinuria are now recognized as complications of trauma, ischemia, surgery, states of exertion and stress, metabolic abnormalities, inherited enzyme disorders, toxin and drug actions, and inflammatory states. Infarction of the heart muscle also can be detected by myoglobin assay. Persistent myoglobinuric states may be complicated by renal failure and electrolyte imbalance. The diagnosis of myoglobinemia and myoglobinuria can be now confirmed with the use of immunoassay techniques. Although not yet widely available, they offer the possibility of the specificity and sensitivity needed for clinical use.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 401372     DOI: 10.3109/10408367809150922

Source DB:  PubMed          Journal:  CRC Crit Rev Clin Lab Sci        ISSN: 0590-8191


  4 in total

1.  Serum myoglobin concentrations are decreased by beta-adrenergic stimulation.

Authors:  S Ljunghall; L E Roxin; P Venge; G Akerström
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

Review 2.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

3.  Myoglobin for Detection of High-Risk Patients with Acute Myocarditis.

Authors:  Jan Kottwitz; Katelyn A Bruno; Jan Berg; Gary R Salomon; DeLisa Fairweather; Mawahib Elhassan; Nora Baltensperger; Christine K Kissel; Marina Lovrinovic; Andrea Baltensweiler; Christian Schmied; Christian Templin; Joao A C Lima; Ulf Landmesser; Thomas F Lüscher; Robert Manka; Bettina Heidecker
Journal:  J Cardiovasc Transl Res       Date:  2020-01-31       Impact factor: 3.216

4.  Biochemical Markers of Myocardial Damage.

Authors:  Geza S Bodor
Journal:  EJIFCC       Date:  2016-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.